Promoting Safe Injection Practices, Substance Use Reduction, Hepatitis C Testing, and Overdose Prevention Among Syringe Service Program Clients Using a Computer-Tailored Intervention: Pilot Randomized Controlled Trial

Karli R Hochstatter, Shawnika J Hull, Ajay K Sethi, Marguerite E Burns, Marlon P Mundt, Ryan P Westergaard, Karli R Hochstatter, Shawnika J Hull, Ajay K Sethi, Marguerite E Burns, Marlon P Mundt, Ryan P Westergaard

Abstract

Background: Syringe service programs (SSPs) are safe, highly effective programs for promoting health among people who inject drugs. However, resource limitations prevent the delivery of a full package of prevention services to many clients in need. Computer-tailored interventions may represent a promising approach for providing prevention information to people who inject drugs in resource-constrained settings.

Objective: The aim of this paper is to assess the effect of a computer-tailored behavioral intervention, called Hep-Net, on safe injection practices, substance use reduction, overdose prevention, and hepatitis C virus (HCV) testing among SSP clients.

Methods: Using a social network-based recruitment strategy, we recruited clients of an established SSP in Wisconsin and peers from their social networks. Participants completed a computerized baseline survey and were then randomly assigned to receive the Hep-Net intervention. Components of the intervention included an overall risk synthesis, participants' selection of a behavioral goal, and an individualized risk reduction exercise. Individuals were followed up 3 months later to assess their behavior change. The effect of Hep-Net on receiving an HCV screening test, undergoing Narcan training, reducing the frequency of drug use, and sharing drug equipment was assessed. The individual's readiness to change each behavior was also examined.

Results: From 2014 to 2015, a total of 235 people who injected drugs enrolled into the Hep-Net study. Of these, 64.3% (151/235) completed the follow-up survey 3-6 months postenrollment. Compared with the control group, individuals who received the Hep-Net intervention were more likely to undergo HCV testing (odds ratio [OR] 2.23, 95% CI 1.05-4.74; P=.04) and receive Narcan training (OR 2.25, 95% CI 0.83-6.06; P=.11), and they shared drug equipment less frequently (OR 0.06, 95% CI 0.55-0.65; P<.001). Similarly, individuals who received the intervention were more likely to advance in their stage of readiness to change these 3 behaviors. However, intervention participants did not appear to reduce the frequency of drug use or increase their readiness to reduce drug use more than control participants, despite the fact that the majority of the intervention participants selected this as the primary goal to focus on after participation in the baseline survey.

Conclusions: Implementing computer-based risk reduction interventions in SSPs may reduce harms associated with the sharing of injection equipment and prevent overdose deaths; however, brief computerized interventions may not be robust enough to overcome the challenges associated with reducing and ceasing drug use when implemented in settings centered on the delivery of prevention services.

Trial registration: ClinicalTrials.gov NCT02474043; https://ichgcp.net/clinical-trials-registry/NCT02474043.

International registered report identifier (irrid): RR1-10.2196/resprot.4830.

Keywords: drug overdose; harm reduction; hepatitis C virus; intravenous drug abuse; web-based intervention.

Conflict of interest statement

Conflicts of Interest: None declared.

©Karli R Hochstatter, Shawnika J Hull, Ajay K Sethi, Marguerite E Burns, Marlon P Mundt, Ryan P Westergaard. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 29.09.2020.

References

    1. National Survey on Drug Use and Health: Detailed Tables. Substance Abuse and Mental Health Services Administration. 2018. [2020-05-01]. .
    1. Overdose Death Rates. National Institute on Drug Abuse (NIDA) 2018. Jan 24, [2020-05-01]. .
    1. Hepatitis C Testing Recommendations. Centers for Disease Control and Prevention. 2015. [2020-05-01]. .
    1. Zibbell JE, Asher AK, Patel RC, Kupronis B, Iqbal K, Ward JW, Holtzman D. Increases in acute hepatitis C virus infection related to a growing opioid epidemic and associated injection drug use, United States, 2004 to 2014. Am J Public Health. 2018 Mar;108(2):175–81. doi: 10.2105/AJPH.2017.304132.
    1. Suryaprasad A, White JZ, Xu F, Eichler BA, Hamilton J, Patel A, Hamdounia SB, Church DR, Barton K, Fisher C, Macomber K, Stanley M, Guilfoyle SM, Sweet K, Liu S, Iqbal K, Tohme R, Sharapov U, Kupronis BA, Ward JW, Holmberg SD. Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006-2012. Clin Infect Dis. 2014 Dec 15;59(10):1411–9. doi: 10.1093/cid/ciu643.
    1. Zibbell JE, Iqbal K, Patel RC, Suryaprasad A, Sanders KJ, Moore-Moravian L, Serrecchia J, Blankenship S, Ward JW, Holtzman D, Centers for Disease ControlPrevention (CDC) Increases in hepatitis C virus infection related to injection drug use among persons aged ≤30 years - Kentucky, Tennessee, Virginia, and West Virginia, 2006-2012. MMWR Morb Mortal Wkly Rep. 2015 May 8;64(17):453–8.
    1. Centers for Disease Control and Prevention (CDC) Notes from the field: hepatitis C virus infections among young adults--rural Wisconsin, 2010. MMWR Morb Mortal Wkly Rep. 2012 May 18;61(19):358.
    1. Centers for Disease Control and Prevention (CDC) Hepatitis C virus infection among adolescents and young adults:Massachusetts, 2002-2009. MMWR Morb Mortal Wkly Rep. 2011 May 6;60(17):537–41.
    1. Christian WJ, Hopenhayn C, Christian A, McIntosh D, Koch A. Viral hepatitis and injection drug use in Appalachian Kentucky: a survey of rural health department clients. Public Health Rep. 2010;125(1):121–8. doi: 10.1177/003335491012500116.
    1. Use of Enhanced Surveillance for Hepatitis C Virus Infection to Detect a Cluster Among Young Injection-Drug Users --- New York, November 2004--April 2007. Centers for Disease Control and Prevention. 2008. [2020-05-01]. .
    1. Peters PJ, Pontones P, Hoover KW, Patel MR, Galang RR, Shields J, Blosser SJ, Spiller MW, Combs B, Switzer WM, Conrad C, Gentry J, Khudyakov Y, Waterhouse D, Owen SM, Chapman E, Roseberry JC, McCants V, Weidle PJ, Broz D, Samandari T, Mermin J, Walthall J, Brooks JT, Duwve JM, Indiana HIV Outbreak Investigation Team HIV infection linked to injection use of oxymorphone in Indiana, 2014-2015. N Engl J Med. 2016 Jul 21;375(3):229–39. doi: 10.1056/NEJMoa1515195.
    1. van Handel MM, Rose CE, Hallisey EJ, Kolling JL, Zibbell JE, Lewis B, Bohm MK, Jones CM, Flanagan BE, Siddiqi A, Iqbal K, Dent AL, Mermin JH, McCray E, Ward JW, Brooks JT. County-level vulnerability assessment for rapid dissemination of HIV or HCV infections among persons who inject drugs, United States. J Acquir Immune Defic Syndr. 2016 Nov 1;73(3):323–31. doi: 10.1097/QAI.0000000000001098.
    1. Hagan H, Jarlais DC, Friedman SR, Purchase D, Alter MJ. Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. Am J Public Health. 1995 Dec;85(11):1531–7. doi: 10.2105/ajph.85.11.1531.
    1. Iversen J, Wand H, Topp L, Kaldor J, Maher L. Reduction in HCV incidence among injection drug users attending needle and syringe programs in Australia: a linkage study. Am J Public Health. 2013 Aug;103(8):1436–44. doi: 10.2105/AJPH.2012.301206.
    1. Aspinall E, Nambiar D, Goldberg DJ, Hickman M, Weir A, van Velzen E, Palmateer N, Doyle JS, Hellard ME, Hutchinson SJ. Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis. Int J Epidemiol. 2014 Mar;43(1):235–48. doi: 10.1093/ije/dyt243.
    1. Vlahov D, Junge B. The role of needle exchange programs in HIV prevention. Public Health Rep. 1998 Jun;113(Suppl 1):75–80.
    1. Kaplan EH. A method for evaluating needle exchange programmes. Stat Med. 1994;13(19-20):2179–87. doi: 10.1002/sim.4780131923.
    1. des Jarlais DC, Perlis T, Arasteh K, Torian LV, Hagan H, Beatrice S, Smith L, Wethers J, Milliken J, Mildvan D, Yancovitz S, Friedman SR. Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001. AIDS. 2005 Oct;19(Suppl 3):S20–5. doi: 10.1097/01.aids.0000192066.86410.8c.
    1. Hagan H, McGough JP, Thiede H, Hopkins S, Duchin J, Alexander E. Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors. J Subst Abuse Treat. 2000 Oct;19(3):247–52. doi: 10.1016/s0740-5472(00)00104-5.
    1. Watters JK, Estilo MJ, Clark GL, Lorvick J. Syringe and needle exchange as HIV/AIDS prevention for injection drug users. J Am Med Assoc. 1994 Jan 12;271(2):115–20.
    1. Marx MA, Brahmbhatt H, Beilenson P, Brookmeyer RS, Strathdee SA, Alexander C, Vlahov D. Impact of needle exchange programs on adolescent perceptions about illicit drug use. AIDS Behav Vol. 2001;5(4):379–86. doi: 10.1023/A:1013195108756.
    1. Syringe Exchange Programs --- United States, 2008. Centers for Disease Control and Prevention. 2010. [2020-05-01]. .
    1. des Jarlais DC. Harm reduction in the USA: the research perspective and an archive to David Purchase. Harm Reduct J. 2017 Jul 26;14(1):51. doi: 10.1186/s12954-017-0178-6.
    1. Rudolph A, Standish K, Amesty S, Crawford N, Stern R, Badillo W, Boyer A, Brown D, Ranger N, Orduna JG, Lasenburg L, Lippek S, Fuller C. A community-based approach to linking injection drug users with needed services through pharmacies: an evaluation of a pilot intervention in New York City. AIDS Educ Prev. 2010 Jul;22(3):238–51. doi: 10.1521/aeap.2010.22.3.238.
    1. Rita O, Regan M, Julita V, Kathrin G. Tailoring Persuasive Health Games to Gamer Type. Proceedings of the SIGCHI Conference on Human Factors in Computing Systems; CHI'13; April 27, 2013; Paris, France. 2013.
    1. Orji R, Moffatt K. Persuasive technology for health and wellness: state-of-the-art and emerging trends. Health Informatics J. 2018 Mar;24(1):66–91. doi: 10.1177/1460458216650979.
    1. Orji T, Mandryk RL. Developing culturally relevant design guidelines for encouraging healthy eating behavior. Int J Hum Comput Stud. 2014 Feb;72(2):207–23. doi: 10.1016/j.ijhcs.2013.08.012.
    1. Krebs P, Prochaska JO, Rossi JS. A meta-analysis of computer-tailored interventions for health behavior change. Prev Med. 2010;51(3-4):214–21. doi: 10.1016/j.ypmed.2010.06.004.
    1. Westergaard RP, Hull SJ, Merkow A, Stephens LK, Hochstatter KR, Olson-Streed HK, Baker LM, Hess TM. Computerized tailored interventions to enhance prevention and screening for hepatitis C virus among people who inject drugs: protocol for a randomized pilot study. JMIR Res Protoc. 2016 Jan 22;5(1):e15. doi: 10.2196/resprot.4830.
    1. Prochaska JO, Velicer WF. The transtheoretical model of health behavior change. Am J Health Promot. 1997;12(1):38–48. doi: 10.4278/0890-1171-12.1.38.
    1. Prochaska JO, Redding CA, Harlow LL, Rossi JS, Velicer WF. The transtheoretical model of change and HIV prevention: a review. Health Educ Q. 1994;21(4):471–86. doi: 10.1177/109019819402100410.
    1. Richards CM, Sharif F, Eischen S, Thomas J, Wang Q, Guo H, Luo X, Okuyemi K. Retention of homeless smokers in the power to quit study. Nicotine Tob Res. 2015 Oct;17(9):1104–11. doi: 10.1093/ntr/ntu210.
    1. Baggett TP, O'Connell JJ, Singer DE, Rigotti NA. The unmet health care needs of homeless adults: a national study. Am J Public Health. 2010 Jul;100(7):1326–33. doi: 10.2105/AJPH.2009.180109.
    1. Marsch LA, Bickel WK. Efficacy of computer-based HIV/AIDS education for injection drug users. Am J Health Behav. 2004;28(4):316–27. doi: 10.5993/ajhb.28.4.3.
    1. Marsch LA, Grabinski MJ, Bickel WK, Desrosiers A, Guarino H, Muehlbach B, Solhkhah R, Taufique S, Acosta M. Computer-assisted HIV prevention for youth with substance use disorders. Subst Use Misuse. 2011;46(1):46–56. doi: 10.3109/10826084.2011.521088.
    1. Ondersma SJ, Chase SK, Svikis DS, Schuster CR. Computer-based brief motivational intervention for perinatal drug use. J Subst Abuse Treat. 2005 Jul;28(4):305–12. doi: 10.1016/j.jsat.2005.02.004.
    1. Ondersma SJ, Svikis DS, Schuster CR. Computer-based brief intervention a randomized trial with postpartum women. Am J Prev Med. 2007 Mar;32(3):231–8. doi: 10.1016/j.amepre.2006.11.003.
    1. Hester RK, Delaney HD. Behavioral self-control program for windows: results of a controlled clinical trial. J Consult Clin Psychol. 1997 Aug;65(4):686–93. doi: 10.1037//0022-006x.65.4.686.
    1. Hester RK, Squires DD, Delaney HD. The Drinker's check-up: 12-month outcomes of a controlled clinical trial of a stand-alone software program for problem drinkers. J Subst Abuse Treat. 2005 Mar;28(2):159–69. doi: 10.1016/j.jsat.2004.12.002.
    1. Bickel WK, Marsch LA, Buchhalter AR, Badger GJ. Computerized behavior therapy for opioid-dependent outpatients: a randomized controlled trial. Exp Clin Psychopharmacol. 2008 May;16(2):132–43. doi: 10.1037/1064-1297.16.2.132.
    1. Carroll KM, Ball SA, Martino S, Nich C, Babuscio TA, Nuro KF, Gordon MA, Portnoy GA, Rounsaville BJ. Computer-assisted delivery of cognitive-behavioral therapy for addiction: a randomized trial of CBT4CBT. Am J Psychiatry. 2008 Jul;165(7):881–8. doi: 10.1176/appi.ajp.2008.07111835.
    1. Gagnon H, Godin G, Alary M, Bruneau J, Otis J. A randomized trial to evaluate the efficacy of a computer-tailored intervention to promote safer injection practices among drug users. AIDS Behav. 2010 Jul;14(3):538–48. doi: 10.1007/s10461-009-9651-x.
    1. Jamner MS, Wolitski RJ, Corby NH. Impact of a longitudinal community HIV intervention targeting injecting drug users' stage of change for condom and bleach use. Am J Health Promot. 1997;12(1):15–24. doi: 10.4278/0890-1171-12.1.15.
    1. Bowen AM, Trotter R. HIV risk in intravenous drug users and crack cocaine smokers: predicting stage of change for condom usep. J Consult Clin Psychol. 1995 May;63(2):238–48. doi: 10.1037//0022-006x.63.2.238.
    1. Patten S, Vollman A, Thurston W. The utility of the transtheoretical model of behavior change for HIV risk reduction in injection drug users. J Assoc Nurses AIDS Care. 2000;11(1):57–66. doi: 10.1016/S1055-3290(06)60422-6.

Source: PubMed

3
Suscribir